Cited 19 times in
Antibody Depletion by Bortezomib through Blocking of Antigen Presentation
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 신재일 | - |
dc.date.accessioned | 2014-12-18T09:24:09Z | - |
dc.date.available | 2014-12-18T09:24:09Z | - |
dc.date.issued | 2013 | - |
dc.identifier.issn | 0028-4793 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/88103 | - |
dc.description.statementOfResponsibility | open | - |
dc.relation.isPartOf | NEW ENGLAND JOURNAL OF MEDICINE | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | ADAM Proteins/immunology* | - |
dc.subject.MESH | Autoantibodies/blood* | - |
dc.subject.MESH | B-Lymphocytes/drug effects* | - |
dc.subject.MESH | Boronic Acids/therapeutic use* | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Plasma Cells/drug effects* | - |
dc.subject.MESH | Protease Inhibitors/therapeutic use* | - |
dc.subject.MESH | Purpura, Thrombotic Thrombocytopenic/immunology* | - |
dc.subject.MESH | Pyrazines/therapeutic use* | - |
dc.title | Antibody Depletion by Bortezomib through Blocking of Antigen Presentation | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Pediatrics (소아과학) | - |
dc.contributor.googleauthor | Se Jin Park | - |
dc.contributor.googleauthor | Hae Il Cheong | - |
dc.contributor.googleauthor | Jae Il Shin | - |
dc.identifier.doi | 10.1056/NEJMc1301264 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A02142 | - |
dc.relation.journalcode | J02371 | - |
dc.identifier.eissn | 1533-4406 | - |
dc.identifier.pmid | 23550684 | - |
dc.identifier.url | http://www.nejm.org/doi/full/10.1056/NEJMc1301264 | - |
dc.subject.keyword | ADAM Proteins/immunology* | - |
dc.subject.keyword | Autoantibodies/blood* | - |
dc.subject.keyword | B-Lymphocytes/drug effects* | - |
dc.subject.keyword | Boronic Acids/therapeutic use* | - |
dc.subject.keyword | Female | - |
dc.subject.keyword | Humans | - |
dc.subject.keyword | Plasma Cells/drug effects* | - |
dc.subject.keyword | Protease Inhibitors/therapeutic use* | - |
dc.subject.keyword | Purpura, Thrombotic Thrombocytopenic/immunology* | - |
dc.subject.keyword | Pyrazines/therapeutic use* | - |
dc.contributor.alternativeName | Shin, Jae Il | - |
dc.contributor.affiliatedAuthor | Shin, Jae Il | - |
dc.rights.accessRights | not free | - |
dc.citation.volume | 368 | - |
dc.citation.number | 14 | - |
dc.citation.startPage | 1364 | - |
dc.citation.endPage | 1365 | - |
dc.identifier.bibliographicCitation | NEW ENGLAND JOURNAL OF MEDICINE, Vol.368(14) : 1364-1365, 2013 | - |
dc.identifier.rimsid | 33056 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.